PA
Perceptive Advisors Portfolio holdings
AUM
$2.67B
This Quarter Return
+16.95%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.46%
AUM
$1.93B
AUM Growth
+$1.93B
(+10%)
Cap. Flow
+$121M
Cap. Flow
% of AUM
6.26%
Top 10 Holdings %
Top 10 Hldgs %
49.18%
Holding
191
New
20
Increased
30
Reduced
38
Closed
68
Top Buys
| 1 |
Puma Biotechnology
PBYI
|
$64.1M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
$58.2M |
| 3 |
DOVA
Dova Pharmaceuticals, Inc. Common Stock
DOVA
|
$38M |
| 4 |
CORI
Corium International, Inc.
CORI
|
$23.8M |
| 5 |
Intuitive Surgical
ISRG
|
$19.4M |
Top Sells
| 1 |
Aclaris Therapeutics
ACRS
|
$37.6M |
| 2 |
Sarepta Therapeutics
SRPT
|
$23M |
| 3 |
NVRO
NEVRO CORP.
NVRO
|
$20.4M |
| 4 |
AVXS
AveXis, Inc. Common Stock
AVXS
|
$14.6M |
| 5 |
AMAG
AMAG Pharmaceuticals, Inc.
AMAG
|
$12.6M |
Sector Composition
| 1 | Healthcare | 96.53% |
| 2 | Consumer Discretionary | 0.06% |
| 3 | Energy | 0.04% |
| 4 | Industrials | 0% |
| 5 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
EGRX
51
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $7.89M | 0.4% |
+100,000
| New | +$7.89M |
|
52
Corbus Pharmaceuticals
CRBP
$121M
| $7.76M | 0.39% |
1,232,500
-17,500
| -1% | -$110K |
|
53
uniQure
QURE
$954M
| $6.75M | 0.34% |
1,090,119
-175,844
| -14% | -$1.09M |
|
|
VIVE
54
DELISTED
VIVEVE MED INC
VIVE
| $6.39M | 0.32% |
890,468
-48,274
| -5% | -$352K |
|
|
NVTA
55
DELISTED
Invitae Corporation
NVTA
| $6.21M | 0.31% |
649,500
+169,500
| +35% | +$1.62M |
|
56
Zymeworks
ZYME
$1.07B
| $6.1M | 0.31% |
+730,768
| New | +$6.1M |
|
57
ANI Pharmaceuticals
ANIP
$2.06B
| $5.87M | 0.3% |
125,399
-129,490
| -51% | -$6.06M |
|
58
Clearside Biomedical
CLSD
$26.7M
| $5.65M | 0.28% |
620,181
-91,881
| -13% | -$837K |
|
59
UnitedHealth
UNH
$279B
| $5.28M | 0.27% |
28,480
+15,480
| +119% | +$2.87M |
|
|
FOMX
60
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $5.18M | 0.26% |
1,117,324
-205,670
| -16% | -$954K |
|
61
UroGen Pharma
URGN
$896M
| $4.86M | 0.24% |
+269,014
| New | +$4.86M |
|
|
ABEOW
62
DELISTED
Abeona Therapeutics Inc. Warrant
ABEOW
| $4.29M | 0.22% |
1,259,636
| – | – |
|
|
SRRA
63
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $4.28M | 0.22% |
3,655,186
-48,518
| -1% | -$56.8K |
|
|
FWP
64
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
| $3.96M | 0.2% |
194,718
-159,523
| -45% | -$3.24M |
|
|
NEPT
65
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
| $3.8M | 0.19% |
6,519,634
| – | – |
|
66
Exact Sciences
EXAS
$9.33B
| $3.54M | 0.18% |
100,000
-310,000
| -76% | -$11M |
|
|
PFNX
67
DELISTED
Pfenex Inc.
PFNX
| $3.39M | 0.17% |
845,973
-46,874
| -5% | -$188K |
|
68
Ocugen
OCGN
$328M
| $3.18M | 0.16% |
1,777,777
| – | – |
|
|
BHVN
69
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $3M | 0.15% |
+120,000
| New | +$3M |
|
70
ADMA Biologics
ADMA
$4.03B
| $2.77M | 0.14% |
721,102
| – | – |
|
71
Abeona Therapeutics
ABEO
$356M
| $2.71M | 0.14% |
422,873
-200,000
| -32% | -$1.28M |
|
|
OCRX
72
DELISTED
Ocera Therapeutics, Inc.
OCRX
| $2.37M | 0.12% |
2,038,880
-111,120
| -5% | -$129K |
|
|
VRNA
73
Verona Pharma
VRNA
$9.18B
| $2.33M | 0.12% |
+200,000
| New | +$2.33M |
|
74
Xenon Pharmaceuticals
XENE
$2.99B
| $2.28M | 0.11% |
723,853
| – | – |
|
|
MGCD
75
DELISTED
MGC Diagnostics Corporation
MGCD
| $2.14M | 0.11% |
252,327
-50,000
| -17% | -$424K |
|